Search Within

Hematologic Malignancies, Division of

  1. "2020"
Formats
  1. Meeting Abstract (439)
  2. Journal Article (325)
  3. Review (65)
  4. Editorial (39)
  5. Research Letter (26)
  6. Guidelines (16)
  7. Correspondence (11)
  8. Book Section (8)
  9. Miscellaneous (7)
Groups
  1. Department of Medicine (926)
  2. Center for Hematologic Malignancies (732)
  3. GSK Faculty (283)
  4. Adult Leukemia (272)
  5. Solid Tumor Oncology Division (212)
  6. Sloan Kettering Institute Postdocs (207)

More Groups

People
  1. Miguel-Angel Perales (93)
  2. Sergio Giralt (91)
  3. Ross Levine (58)
  4. Sean Devlin (55)
  5. Michael Scordo (53)
  6. Anthony Mato (52)

More People

Years
  1. 2020 (936)
Publications
  1. Blood (169)
  2. Journal of Clinical Oncology (84)
  3. Biology of Blood and Marrow Transplantation (77)
  4. Blood Advances (36)
  5. Clinical Lymphoma, Myeloma and Leukemia (29)
  6. Leukemia and Lymphoma (29)

More Publications

Publishers
  1. American Society of Hematology (209)
  2. Elsevier Inc. (159)
  3. American Society of Clinical Oncology (91)
  4. Nature Publishing Group (76)
  5. American Association for Cancer Research (61)
  6. Taylor & Francis Group (35)

More Publishers

Results (936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 study of LY3410738, a first-in-class covalent inhibitor of mutant IDH in advanced myeloid malignancies (trial in progress)
    Meeting Abstract

    Stein, E. M.; Konopleva, M.; Gilmour, R.; Szpurka, A. M.; Hill, E.; Ward, R.; Kantarjian, H. M.; Dinardo, C. D.
    Blood (2020)

    Fulltext@MSK | Save
  • Brentuximab vedotin with chemotherapy for patients with previously untreated, stage III/IV classical hodgkin lymphoma: 5-year update of the ECHELON-1 study
    Meeting Abstract

    Straus, D. J.; Dlugosz-Danecka, M.; Connors, J. M.; Illés, A.; Picardi, M.; Lech-Marańda, E.; Feldman, T.; Smolewski, P.; Savage, K. J.; Bartlett, N. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • The tumor associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B-cell lymphoma
    Meeting Abstract

    Takata, K.; Chong, L. C.; Ennishi, D.; Thakur, A.; Healy, S.; Viganò, E.; Dao, T.; Nielsen, J. S.; Ben-Neriah, S.; Aoki, T.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Initial results from a biomarker-directed phase 2 trial of SY-1425, a potent and selective RAR alpha agonist, in combination with azacitidine in relapsed/refractory acute myeloid leukemia
    Meeting Abstract

    Stein, E. M.; De Botton, S.; Cluzeau, T.; Pigneux, A.; Liesveld, J. L.; Cook, R. J.; Rousselot, P.; Rizzieri, D. A.; Braun, T.; Bixby, D. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Enasidenib (ENA) monotherapy with addition of azacitidine in non-responders is effective in older patients with newly diagnosed IDH2 mutated acute myeloid leukemia (AML): A completed phase 2/1b sub-study of the beat AML master trial
    Meeting Abstract

    Stein, E. M.; Huang, Y.; Borate, U.; Baer, M. R.; Stock, W.; Kovacsovics, T.; Blum, W.; Schiller, G. J.; Olin, R. L.; Foran, J. M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Venetoclax therapy for relapsed and treatment refractory AML: Clinical outcomes and molecular predictors
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J. L.; King, A. C.; Daniyan, A.; Famulare, C.; Cuello, B. M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical outcomes of acute myeloid leukemia patients bridged to allogeneic stem cell transplant by venetoclax combination therapy
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; Barker, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Maintenance use is more important than the choice of bortezomib-based triplet induction in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation
    Meeting Abstract

    Sidana, S.; Kumar, S. K.; Fraser, R.; Estrada-Merly, N.; Norkin, M.; Giralt, S.; Qazilbash, M. H.; Shah, N.; D'Souza, A.
    Blood (2020)

    Fulltext@MSK | Save
  • Bridging the gap in access to transplant for underserved minority patients using mismatched unrelated donors and post-transplant cyclophosphamide: A National Marrow Donor Program/Be The Match (NMDP/BTM) Initiative
    Meeting Abstract

    Shaw, B. E.; Jimenez-Jimenez, A.; Burns, L. J.; Logan, B.; Khimani, F.; Shaffer, B. C.; Shah, N. N.; Mussetter, A.; Tang, X. Y.; McCarty, J. M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save